Last reviewed · How we verify

NCT03865589

Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

Active, enrolled NA Last updated 8 January 2026
What this trial tests

NA trial testing Ultrasound Elastography in Bone Marrow Transplant Complications in 250 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 April 2019
Primary endpoint
30 June 2026
30 June 2027

Quick facts

Lead sponsorChildren's Mercy Hospital Kansas City
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment250
Start date1 April 2019
Primary completion30 June 2026
Estimated completion30 June 2027
Sites7 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Mercy Hospital Kansas City

Who can join

Adults 1 Month to 99, any sex, with Bone Marrow Transplant Complications or Sinusoidal Obstruction Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obstruction syndrome (SOS), mild to moderate SOS, and severe to very severe SOS. Secondarily, the investigators would also like to quantify the temporal relationship between US SWE changes and SOS diagnosis according to various clinical criteria (Modified Seattle, Baltimore, EBMT consortium).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound Elastography

Trials testing the same drug.

Other recruiting trials for Bone Marrow Transplant Complications

Currently open trials in the same condition.

Other Children's Mercy Hospital Kansas City trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03865589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing